-
RXRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Recursion Pharmaceuticals (RXRX)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 603.02 mm | 603.02 mm | 603.02 mm | 603.02 mm | 603.02 mm | 603.02 mm |
Cash burn (monthly) | (no burn) | (no burn) | 61.26 mm | 39.92 mm | 38.48 mm | 29.93 mm |
Cash used (since last report) | n/a | n/a | 129.68 mm | 84.51 mm | 81.46 mm | 63.37 mm |
Cash remaining | n/a | n/a | 473.34 mm | 518.52 mm | 521.57 mm | 539.66 mm |
Runway (months of cash) | n/a | n/a | 7.7 | 13.0 | 13.6 | 18.0 |
13F holders | Current |
---|---|
Total holders | 314 |
Opened positions | 85 |
Closed positions | 39 |
Increased positions | 113 |
Reduced positions | 58 |
13F shares | Current |
---|---|
Total value | 2.04 tn |
Total shares | 316.59 mm |
Total puts | 3.64 mm |
Total calls | 2.82 mm |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 34.01 mm | $229.91 bn |
ARK Investment Management | 32.35 mm | $218.66 bn |
Baillie Gifford & Co | 24.86 mm | $168.08 bn |
BlackRock | 23.44 mm | $158.43 bn |
SFTBY SoftBank | 14.67 mm | $99.15 bn |
Mubadala Investment Co PJSC | 12.99 mm | $87.78 bn |
STT State Street | 12.58 mm | $85.03 bn |
Kinnevik AB (publ) | 11.91 mm | $80.48 bn |
Novo Holdings A/S | 10.11 mm | $68.37 bn |
MIC Capital Management UK | 9.64 mm | $65.19 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Feb 25 | Christopher Gibson | Class A Common Stock | Payment of exercise | Dispose F | No | No | 10.64 | 17,132 | 182.28 k | 1,256,024 |
18 Feb 25 | Taylor Ben R | Class A Common Stock | Payment of exercise | Dispose F | No | No | 10.64 | 10,879 | 115.75 k | 875,727 |
6 Feb 25 | Christopher Gibson | Class A Common Stock | Sell | Dispose S | No | Yes | 8.12 | 20,000 | 162.40 k | 1,273,156 |
6 Feb 25 | Christopher Gibson | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 20,000 | 0.00 | 1,293,156 |
6 Feb 25 | Christopher Gibson | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 20,000 | 0.00 | 5,936,700 |
5 Feb 25 | Christopher Gibson | Class A Common Stock | Sell | Dispose S | No | Yes | 7.68 | 20,000 | 153.60 k | 1,273,156 |
5 Feb 25 | Christopher Gibson | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 20,000 | 0.00 | 1,293,156 |
5 Feb 25 | Christopher Gibson | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 20,000 | 0.00 | 5,956,700 |
3 Feb 25 | Najat Khan | Class A Common Stock | Payment of exercise | Dispose F | No | No | 7.25 | 2,753 | 19.96 k | 712,381 |
3 Feb 25 | Najat Khan | Class A Common Stock | Grant | Acquire A | No | No | 0 | 8,049 | 0.00 | 715,134 |